Homepage > Company > Media > Pharma News > 2021 > Full FDA Approval for COVID-19 Vaccine May Come in ‘Couple of Months,’ Report Says

Full FDA Approval for COVID-19 Vaccine May Come in ‘Couple of Months,’ Report Says

Full FDA approval for COVID-19 vaccines could come within the next couple of months, CNN reports. Federal officials told the outlet the Food and Drug Administration is working “as fast as possible” to review the applications, though it aims to avoid any appearance of political pressure.

The Biden administration has hoped full approval could dampen vaccine hesitancy, giving people more confidence to get vaccinated, but it understands it won’t necessarily be a game-changer. “Yes, it will be another tool in the toolkit. We aren’t naive to think it will suddenly change all minds,” a Biden adviser told CNN. The move could also give U.S. businesses the tool they need to implement vaccine mandates.

Pfizer and Moderna, the two producers of mRNA vaccines approved for emergency use, have both filed for full regulatory approval. Johnson & Johnson, the only other vaccine approved, has not yet filed an application.

Published Jul. 30, 2021

https://www.thedailybeast.com/

Read also

Spinogenix’s ALS hopeful to advance to registrational trial

Spinogenix’s first-in-class ALS treatment, SPG302 has been shown to slow disease progression in 82% of patients during a Phase IIa study.

FDA Approves First Treatment for Rare Thymidine Kinase 2 Deficiency

Thymidine kinase 2 deficiency (TK2d) is an ultra-rare (1.64 cases per 1,000,000 people) often fatal, genetic mitochondrial disease characterized by progressive and severe muscle weakne...

Cencora

Cencora to invest $1bn in US pharma distribution network

Celltrion

Celltrion Signs Licensing Deal with U.S. Kaigene for Two Antibody Drug Candidates